WINONA LAMBDIN: Open Payments
NPI 1245535848 · PROVIDENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 40 payments from 9 companies in 2025. Trend: 2023 $307 · 2024 $482 · 2025 $984
Food & beverage: $984
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $270 |
| Axsome Therapeutics, Inc. | 9 | $234 |
| Novo Nordisk Inc | 5 | $189 |
| AstraZeneca Pharmaceuticals LP | 2 | $144 |
| Lilly USA, LLC | 3 | $48 |
| Corcept Therapeutics | 2 | $38 |
| PFIZER INC. | 1 | $26 |
| Amgen Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Auvelity, Wegovy, FARXIGA, UBRELVY, VRAYLAR, MOUNJARO, Korlym, Ozempic.
Industry payments across KY — which companies pay providers there.
